Femcity Hospital Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 15-12-2024
- Paid Up Capital ₹ 1.40 Cr
as on 15-12-2024
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.45 Cr
as on 15-12-2024
- Revenue 2.21%
(FY 2022)
- Profit -2.84%
(FY 2022)
- Ebitda -1.07%
(FY 2022)
- Net Worth -88.35%
(FY 2022)
- Total Assets -13.48%
(FY 2022)
About Femcity Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.40 Cr.
The company currently has active open charges totaling ₹1.45 Cr.
Mohammed Khan, Elmeera Siddiqi, and Saritha Pingili serve as directors at the Company.
- CIN/LLPIN
U85300TG2017PTC114524
- Company No.
114524
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Feb 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Femcity Hospital?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohammed Khan  | Managing Director | 06-Feb-2017 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Elmeera Siddiqi | Director | 06-Feb-2017 | Current |
| Saritha Pingili | Director | 11-Jul-2019 | Current |
Financial Performance of Femcity Hospital.
Femcity Hospital Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.21% increase. The company also saw a slight decrease in profitability, with a 2.84% decrease in profit. The company's net worth observed a substantial decline by a decrease of 88.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Femcity Hospital?
In 2021, Femcity Hospital had a promoter holding of 12.02% and a public holding of 87.98%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Jan 2024 | ₹1.58 M | Open |
Others Creation Date: 29 Dec 2022 | ₹4.23 M | Open |
Others Creation Date: 30 Oct 2018 | ₹8.73 M | Open |
How Many Employees Work at Femcity Hospital?
Femcity Hospital has a workforce of 4 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Femcity Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Femcity Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
